What is a stock summary page? Click here for an overview.
Business Description
Viva Biotech Holdings
NAICS : 541714
SIC : 2834
ISIN : KYG9390W1015
Compare
Compare
Traded in other countries / regions
01873.Hong KongVB0.GermanyVBIZF.USA IPO Date
2019-09-13Description
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.55 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 4.61 | |||||
| Interest Coverage | 2 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.96 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 30.2 | |||||
| 3-Year EPS without NRI Growth Rate | -19.8 | |||||
| 3-Year Book Growth Rate | -6.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.91 | |||||
| 14-Day RSI | 99.13 | |||||
| 3-1 Month Momentum % | 13.91 | |||||
| 6-1 Month Momentum % | 158.8 | |||||
| 12-1 Month Momentum % | 27.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 1.15 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 80.59 | |||||
| Days Sales Outstanding | 72.63 | |||||
| Days Payable | 79.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | 14.24 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.65 | |||||
| Operating Margin % | 12.05 | |||||
| Net Margin % | -0.11 | |||||
| FCF Margin % | 0.15 | |||||
| ROE % | -0.06 | |||||
| ROA % | -0.03 | |||||
| ROIC % | 0.99 | |||||
| 3-Year ROIIC % | 42.91 | |||||
| ROC (Joel Greenblatt) % | 9.63 | |||||
| ROCE % | 3.86 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.3 | |||||
| PB Ratio | 1.25 | |||||
| Price-to-Tangible-Book | 4.28 | |||||
| Price-to-Free-Cash-Flow | 1159.59 | |||||
| Price-to-Operating-Cash-Flow | 20.9 | |||||
| EV-to-EBIT | 22.61 | |||||
| EV-to-EBITDA | 11.47 | |||||
| EV-to-Revenue | 2.39 | |||||
| EV-to-FCF | 1542.21 | |||||
| Price-to-GF-Value | 1.11 | |||||
| Price-to-Projected-FCF | 3.74 | |||||
| Earnings Yield (Greenblatt) % | 4.42 | |||||
| FCF Yield % | 0.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VBIZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viva Biotech Holdings Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 277.264 | ||
| EPS (TTM) ($) | -0.013 | ||
| Beta | 1.6 | ||
| 3-Year Sharpe Ratio | 0.38 | ||
| 3-Year Sortino Ratio | 0.89 | ||
| Volatility % | 269.21 | ||
| 14-Day RSI | 99.13 | ||
| 14-Day ATR ($) | 0.00913 | ||
| 20-Day SMA ($) | 0.224978 | ||
| 12-1 Month Momentum % | 27.26 | ||
| 52-Week Range ($) | 0.05 - 0.2993 | ||
| Shares Outstanding (Mil) | 2,112.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Viva Biotech Holdings Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Viva Biotech Holdings Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Viva Biotech Holdings Frequently Asked Questions
What is Viva Biotech Holdings(VBIZF)'s stock price today?
The current price of VBIZF is $0.30. The 52 week high of VBIZF is $0.30 and 52 week low is $0.05.
When is next earnings date of Viva Biotech Holdings(VBIZF)?
The next earnings date of Viva Biotech Holdings(VBIZF) is 2025-09-26 Est..
Does Viva Biotech Holdings(VBIZF) pay dividends? If so, how much?
Viva Biotech Holdings(VBIZF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers